21 results for author:"Wiman B." in Literature citations
Results Customize
› Repeat search in UniProtKB (5)
| A new method measuring the interaction between von Willebrand factor and coagulation factor VIII. Karlman M., Holmstrom M., Wiman B. Thromb. Res. 127:47-50(2011) · Mapped (18) |
| Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Sagoo G.S., Tatt I., Salanti G., Butterworth A.S., Sarwar N., van Maarle M., Jukema J.W., Wiman B., Kastelein J.J., Bennet A.M. et al. Am. J. Epidemiol. 168:1233-1246(2008) · Mapped (9) |
| Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity. Agren A., Wiman B., Schulman S. Blood Coagul. Fibrinolysis 18:657-660(2007) · Mapped (4) |
| Association of apolipoprotein E genotypes with lipid levels and coronary risk. Bennet A.M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., Keavney B., Collins R., Wiman B., de Faire U. et al. JAMA 298:1300-1311(2007) · Mapped (5) |
| The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration. Mannila M.N., Eriksson P., Leander K., Wiman B., de Faire U., Hamsten A., Silveira A. J. Intern. Med. 261:138-147(2007) · Mapped (13) |
| Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis. Agren A., Wiman B., Stiller V., Lindmarker P., Sten-Linder M., Carlsson A., Holmstrom M., Odeberg J., Schulman S. J. Thromb. Haemost. 4:201-208(2006) · Mapped (4) |
| Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Bennet A.M., van Maarle M.C., Hallqvist J., Morgenstern R., Frostegard J., Wiman B., Prince J.A., de Faire U. Atherosclerosis 187:408-414(2006) · Mapped (6) |
| Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Wang X., Ria M., Kelmenson P.M., Eriksson P., Higgins D.C., Samnegard A., Petros C., Rollins J., Bennet A.M., Wiman B. et al. Nat. Genet. 37:365-372(2005) · Mapped (11) |
| Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Edfeldt K., Bennet A.M., Eriksson P., Frostegard J., Wiman B., Hamsten A., Hansson G.K., de Faire U., Yan Z.Q. Eur. Heart J. 25:1447-1453(2004) · Mapped (1) |
| Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Prokunina L., Padyukov L., Bennet A., de Faire U., Wiman B., Prince J., Alfredsson L., Klareskog L., Alarcon-Riquelme M. Arthritis Rheum. 50:1770-1773(2004) · Mapped (4) |
| Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction. Yasar U., Bennet A.M., Eliasson E., Lundgren S., Wiman B., De Faire U., Rane A. Pharmacogenetics 13:715-720(2003) · Mapped (12) |
| Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Bennet A.M., Prince J.A., Fei G.Z., Lyrenas L., Huang Y., Wiman B., Frostegard J., Faire U. Atherosclerosis 171:359-367(2003) · Mapped (5) |
| PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP). Leander K., Wiman B., Hallqvist J., Sten-Linder M., de Faire U. Thromb. Haemost. 89:1064-1071(2003) · Mapped (4) |
| Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. Yasar U., Lundgren S., Eliasson E., Bennet A., Wiman B., de Faire U., Rane A. Biochem. Biophys. Res. Commun. 299:25-28(2002) · Mapped (7) |
| Identification of a PAI-1 binding site in vitronectin. Sigurdardottir O., Wiman B. Biochim. Biophys. Acta 1208:104-110(1994) · UniProtKB (2) |
| Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Bock S.C., Skriver K., Nielsen E., Thoegersen H.-C., Wiman B., Donaldson V.H., Eddy R.L., Marrinan J., Radziejewska E., Huber R. et al. Biochemistry 25:4292-4301(1986) · UniProtKB (1) · Mapped (2) |
| Amino-acid sequence of human alpha 2-antiplasmin. Lijnen H.R., Holmes W.E., van Hoef B., Wiman B., Rodriguez H., Collen D. Eur. J. Biochem. 166:565-574(1987) · UniProtKB (1) · Mapped (1) |
| Primary structure of the B-chain of human plasmin. Wiman B. Eur. J. Biochem. 76:129-137(1977) · UniProtKB (1) |
| Amino-acid sequence of the cyanogen-bromide fragment from human plasminogen that forms the linkage between the plasmin chains. Wiman B., Wallen P. Eur. J. Biochem. 58:539-547(1975) · UniProtKB (1) |
| Structural relationship between 'glutamic acid' and 'lysine' forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography. Wiman B., Wallen P. Eur. J. Biochem. 50:489-494(1975) · UniProtKB (1) |
| Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma. Wiman B., Collen D. Eur. J. Biochem. 78:19-26(1977) · UniProtKB (1) |